No Data
CNS, Fanpep, and others.
＜4076＞CNS has revised its forecast, and the end-of-term Dividends per share is set at 75.00 yen, up from 49.00 yen (including a 40th Anniversary commemorative Dividends of 49.00 yen). ＜4258＞Amiya has finished the acquisition of its own shares. ＜4588＞OncoRis has obtained a business license for regenerative medicine product manufacturing and sales. ＜4881＞FanPep has started administering an allergy Vaccine to subjects in its clinical trials. ＜4890＞Tsubota Lab has commenced a domestic Phase II trial of TLM-003 targeted at myopia patients.
Premium Stocks News = The theory of Prime Minister Ishiba's resignation is gaining strength, and attention is once again focused on "related to Takai."
The imposition of reciprocal tariffs announced by President Trump is shocking the world. There is a concern that it could significantly impact the Japanese economy, and the pressure on the Ishiba administration seems likely to intensify. Within the ruling Liberal Democratic Party, calls for the Prime Minister's resignation are being openly voiced, and there is potential for political expansion ahead of the House of Councillors elections in July. <Considering the diplomatic crisis and the House of Councillors elections> At a meeting held on the 3rd by the "Conservative Unity Association," composed of conservative members of the Liberal Democratic Party, demands for resignation were raised, stating "The Ishiba administration cannot win the House of Councillors elections."
Amanoya --- acquired 0.05 million own Stocks, with a total acquisition amount of 0.177 billion yen.
On the 2nd, Net House <4258> announced the status of treasury stock acquisition in accordance with Article 165, Paragraph 2 of the Companies Act. During the period from March 1 to March 31, 2025, 50,900 shares of common stock were acquired through market purchases on the Tokyo Stock Exchange. The total acquisition cost amounted to 177,828,500 yen. This treasury stock acquisition is based on the resolution passed at the board of directors meeting held on March 3, 2025, which set a limit of 0.1 million shares of common stock.
Amiya: Confirmation
Amiya: Financial Report - 29th Term (2024/01/01 - 2024/12/31)
Amiya: Interim report.
